Cap1 analog

LZCap^®AG(3'Acm) LZCap^®AG(3'FMom) LZCap^®AG(AM) LZCap^®AG(FM) LZCap^®AU(3'Acm) LZCap^®AG(3'Ma-Biotin) LZCap^®AG(3'Ma-Peg5-FAM) LZCap^®AG(3'Ma-Cy3) LZCap^®AG(3'Ma-Cy5) LZCap^®AG(3'Ma-Cy7)

Capping kit

LZCap^®AG(3'Acm) Capping Kit LZCap^®AG(3'Acm) Capping Kit (N1-Me-pUTP) LZCap^®AG(3'Ma-Cy5) Capping Kit (N1-Me-pUTP) LZCap^®AG(3'Ma-Cy7) Capping Kit (N1-Me-pUTP)

Modified nucleotide

pUTP N1-Me-pUTP 5mCTP m6ATP 5OMeUTP N7-Methy-GTP 5mUTP 5OHmCTP 5OHmUTP ATP-αS CTP-αS GTP-αS UTP-αS EDA-ATP-MANT (3'Ome)GTP-αS (3'Ome)GTP dATP-αS Biotin-11-dUTP Biotin-16-dUTP Cy5-UTP

Nucleotide

dATP dGTP dCTP dTTP ATP GTP CTP UTP

mRNA Stock solution

LZCap^®AG(3'Acm) Firefly luc mRNA LZCap^®AG(3'Acm) eGFP mRNA LZCap^®AG(3'Acm) RFP mRNA LZCap^®AG(3'Acm) mCherry mRNA LZCap^®AG(3'Acm) RLuc mRNA LZCap^®AG(3'Acm) GLuc mRNA LZCap^®AG(3'Acm) Cas9 mRNA

Synthesis Services

Modified nucleotides Ionizable cationic lipids

pUTP

Cat.NO.	HN1001
Molecular Formula	C₉H₁₅N₂O₁₅P₃（Free acid）
Molecular Weight	484.14（Free acid）
CAS	2564-35-4（Free acid）
Concentration	100 mM
Specifications	100 μL、1 mL
Purity	HPLC ≥99%
Salt type	Na⁺
Storage Conditions	store at -15°C.

Details

Download

Description: Pseudouridine，pUTP，It is a modified pyrimidine nucleotide. The incorporation of pUTP in the production of mRNA vaccines and drugs increases the expression of mRNA and decreases the immunogenicity of mRNA in vivo, and the immunogenicity of mRNA decreases with the increase ratio of pUTP introduction.

HN1001-pUTP-instruction.pdf

218.22KB

Download